Experiment 958326

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

LEUCINE

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTIVIRAL ACTIVITY
Administration routeIV
OrganismEmpty organism
CitationHAJEK,E:. (1989). USE OF LEUCINE AS A DRUG AGAINST AIDS.. ()
Amount utilized
Compound isolated
DiseaseDAILY DOSING FOR 3-7 DAYS. PATIENT MUST RECEIVE NO OTHER PROTEIN OR AMINO ACID NUTRITION. LEUCINE BREAKS THE SS BRIDGES ON CYSTINE AT VARIOUS SITES OF THE HIV GENOME, KILLING THE VIRUS.
Dose amount>0.5 GM
Number2
Qualitative result.
AnimalHUMAN ADULT
Per unitKG
Dose expressionCONC USED